Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Other financing activities (2020 - 2023)

NeuroPace has reported Other financing activities over the past 4 years, most recently at $186000.0 for Q4 2023.

  • Quarterly results put Other financing activities at $186000.0 for Q4 2023, down 46.4% from a year ago — trailing twelve months through Sep 2024 was $186000.0 (down 60.09% YoY), and the annual figure for FY2023 was $305000.0, down 12.1%.
  • Other financing activities for Q4 2023 was $186000.0 at NeuroPace, up from $9000.0 in the prior quarter.
  • Over the last five years, Other financing activities for NPCE hit a ceiling of $1.8 million in Q2 2021 and a floor of -$117000.0 in Q3 2020.
  • Median Other financing activities over the past 4 years was $186000.0 (2023), compared with a mean of $472666.7.
  • Biggest five-year swings in Other financing activities: skyrocketed 1447.01% in 2021 and later tumbled 46.4% in 2023.
  • NeuroPace's Other financing activities stood at $210000.0 in 2020, then surged by 761.9% to $1.8 million in 2021, then plummeted by 80.83% to $347000.0 in 2022, then crashed by 46.4% to $186000.0 in 2023.
  • The last three reported values for Other financing activities were $186000.0 (Q4 2023), $9000.0 (Q2 2023), and $110000.0 (Q1 2023) per Business Quant data.